Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
2.
Histochem Cell Biol ; 146(6): 757-768, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27663455

ABSTRACT

The purinergic receptor P2X7 represents an ATP-gated ionotropic receptor with a selective localization in alveolar epithelial type I cells of the lung. Despite the involvement of the receptor in inflammatory processes of the lung, it is not established whether this receptor plays a specific role in the alveolar epithelial cell biology. There is evidence that P2X7 receptor influences Wnt/ß-catenin signalling pathways in alveolar epithelial cells under conditions of injury. Here, we investigated the expression of GSK-3ß, a potent protein kinase involved in alveolar epithelial barrier functions, and of tight junction molecules occludin, claudin-4 and claudin-18 in wild-type and P2X7-/- mice. Western blot analysis, immunohistochemistry and quantitative real-time RT-PCR revealed a remarkable increase in claudin-18 mRNA and protein in lungs of P2X7-/- mice animals. Furthermore, alveolar epithelial cells from P2X7-/- animals showed decreased levels of GSK-3ß protein and its inactive form GSK-3ß (pS9). Conversely, claudin-18 knockout mice exhibited decreased P2X7 mRNA transcript abundance as measured by mRNA expression microarray and quantitative PCR. Our data are consistent with the hypothesis that P2X7R contributes to alveolar epithelial barrier function through effects on GSK-3ß. Furthermore, these data suggest a potential reciprocal regulation of claudin-18 and P2X7R in the alveolar epithelium.


Subject(s)
Alveolar Epithelial Cells/metabolism , Claudins/metabolism , Glycogen Synthase Kinase 3 beta/metabolism , Lung/cytology , Receptors, Purinergic P2X7/metabolism , Animals , Claudins/deficiency , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Purinergic P2X7/deficiency
3.
Histochem Cell Biol ; 121(2): 131-40, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14752665

ABSTRACT

Precision-cut rat lung slices have been employed in combination with an extensive immunohistochemistry of paraffin-embedded slices for monitoring of early pathohistological changes after exposure to CdCl(2)/TGF-beta(1). Three days of CdCl(2) exposure in combination with TGF-beta(1) seem to be sufficient to induce lung injury with alterations similar to changes observed in early lung fibrogenesis: (1) extracellular matrix accumulation and myofibroblast transdifferentiation (Sirius red staining, collagen type IV, alpha-smooth muscle actin), (2) type I cell injury with loss of type I cell antigens (T1alpha antigen, aquaporin-5, RAGE), (3) increased apoptosis of pulmonary cells (active caspase-3, vimentin cleavage product V1 of caspase-9), and (4) activation of microvascular endothelial cells (podocalyxin, caveolin-1). Western blot analysis confirmed the increasing amount of alpha-smooth muscle actin, the loss of T1alpha antigen, and the increase in caveolin-1 immunoreactivity. The explant culture using CdCl(2)/TGF-beta(1) provides a suitable tool for the study of other factors involved in pulmonary pathology including transcription factors, cytokines, and other metabolites involved in early stages of fibrogenesis.


Subject(s)
Cadmium Chloride/toxicity , Lung/drug effects , Pulmonary Fibrosis/chemically induced , Transforming Growth Factor beta/toxicity , Actins/analysis , Animals , Apoptosis/drug effects , Biomarkers/analysis , Caveolin 1 , Caveolins/analysis , Disease Models, Animal , Drug Combinations , Immunohistochemistry , Lung/chemistry , Lung/pathology , Membrane Glycoproteins , Membrane Proteins/analysis , Organ Culture Techniques , Pulmonary Fibrosis/pathology , Rats , Rats, Wistar , Transforming Growth Factor beta1
SELECTION OF CITATIONS
SEARCH DETAIL